Monoclonal antibody OKI-1Alternative Names: OKI-1 antibody; OKI-a1; OKIa1 monoclonal antibody
Latest Information Update: 08 Aug 2002
At a glance
- Originator Ortho-McNeil
- Class Gene therapies; Monoclonal antibodies
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 31 Mar 1995 Preclinical development for Transplant rejection in Japan (Unknown route)